Conversely, Sepantronium bromide and Trametinib showed a trend of decreased IC50 values in the high-risk group (Fig. 6 G, H), suggesting that these drugs may be more effective in this population.
← all excerpts
Comprehensive characterization of the molecular feature of acetylation in colorectal cancer using integrated single-cell and bulk RNA sequencing.
1
—
—